APO Research, Inc.

APO RESEARCH · REPORT

Injectable Skin Fillers

Selected research

Industry Research

Injectable Skin Fillers Industry Research Report 2026

Market perspective

The global Injectable Skin Fillers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Injectable Skin Fillers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Injectable Skin Fillers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Injectable Skin Fillers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Injectable Skin Fillers include Jingjia Medical, Bloomage Bio, Haohai Biological, Beijing IMEIK, AbbVie, Teoxane, Suneva Medical, Sinclair and SciVision Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Injectable Skin Fillers market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Injectable Skin Fillers Market by Company

Jingjia Medical

Bloomage Bio

Haohai Biological

Beijing IMEIK

AbbVie

Teoxane

Suneva Medical

Sinclair

SciVision Biotech

Q.O.Fill (JW Pharmaceutical)

Prollenium

Merz

Medytox

Matex-Lab

LG Life Sciences

HUGEL

Genoss

Galderma

Elravie (Humedix)

Croma-Pharma

Cleviel (Pharma Research Products)

CG Bio

Caregen

Bohus BioTech

Injectable Skin Fillers Segment by Type

Collagen

CaHA

Hyaluronic Acid

Others

Injectable Skin Fillers Segment by Application

Specialist and Dermatology Clinic

Hospitals and Clinics

Others

Injectable Skin Fillers Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Skin Fillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Skin Fillers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Skin Fillers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Injectable Skin Fillers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Injectable Skin Fillers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Injectable Skin Fillers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Injectable Skin Fillers Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Injectable Skin Fillers Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Injectable Skin Fillers Sales Market Share by Manufacturers (2021-2026) Table 8. Global Injectable Skin Fillers Revenue of Manufacturers (2021-2026) Table 9. Global Injectable Skin Fillers Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Injectable Skin Fillers Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Injectable Skin Fillers Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Injectable Skin Fillers, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Injectable Skin Fillers, Product Type & Application Table 14. Global Injectable Skin Fillers Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Injectable Skin Fillers by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Jingjia Medical Company Information Table 19. Jingjia Medical Business Overview Table 20. Jingjia Medical Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Jingjia Medical Injectable Skin Fillers Product Portfolio Table 22. Jingjia Medical Recent Developments Table 23. Bloomage Bio Company Information Table 24. Bloomage Bio Business Overview Table 25. Bloomage Bio Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Bloomage Bio Injectable Skin Fillers Product Portfolio Table 27. Bloomage Bio Recent Developments Table 28. Haohai Biological Company Information Table 29. Haohai Biological Business Overview Table 30. Haohai Biological Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Haohai Biological Injectable Skin Fillers Product Portfolio Table 32. Haohai Biological Recent Developments Table 33. Beijing IMEIK Company Information Table 34. Beijing IMEIK Business Overview Table 35. Beijing IMEIK Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Beijing IMEIK Injectable Skin Fillers Product Portfolio Table 37. Beijing IMEIK Recent Developments Table 38. AbbVie Company Information Table 39. AbbVie Business Overview Table 40. AbbVie Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. AbbVie Injectable Skin Fillers Product Portfolio Table 42. AbbVie Recent Developments Table 43. Teoxane Company Information Table 44. Teoxane Business Overview Table 45. Teoxane Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Teoxane Injectable Skin Fillers Product Portfolio Table 47. Teoxane Recent Developments Table 48. Suneva Medical Company Information Table 49. Suneva Medical Business Overview Table 50. Suneva Medical Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Suneva Medical Injectable Skin Fillers Product Portfolio Table 52. Suneva Medical Recent Developments Table 53. Sinclair Company Information Table 54. Sinclair Business Overview Table 55. Sinclair Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Sinclair Injectable Skin Fillers Product Portfolio Table 57. Sinclair Recent Developments Table 58. SciVision Biotech Company Information Table 59. SciVision Biotech Business Overview Table 60. SciVision Biotech Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. SciVision Biotech Injectable Skin Fillers Product Portfolio Table 62. SciVision Biotech Recent Developments Table 63. Q.O.Fill (JW Pharmaceutical) Company Information Table 64. Q.O.Fill (JW Pharmaceutical) Business Overview Table 65. Q.O.Fill (JW Pharmaceutical) Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Q.O.Fill (JW Pharmaceutical) Injectable Skin Fillers Product Portfolio Table 67. Q.O.Fill (JW Pharmaceutical) Recent Developments Table 68. Prollenium Company Information Table 69. Prollenium Business Overview Table 70. Prollenium Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Prollenium Injectable Skin Fillers Product Portfolio Table 72. Prollenium Recent Developments Table 73. Merz Company Information Table 74. Merz Business Overview Table 75. Merz Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merz Injectable Skin Fillers Product Portfolio Table 77. Merz Recent Developments Table 78. Medytox Company Information Table 79. Medytox Business Overview Table 80. Medytox Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Medytox Injectable Skin Fillers Product Portfolio Table 82. Medytox Recent Developments Table 83. Matex-Lab Company Information Table 84. Matex-Lab Business Overview Table 85. Matex-Lab Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Matex-Lab Injectable Skin Fillers Product Portfolio Table 87. Matex-Lab Recent Developments Table 88. LG Life Sciences Company Information Table 89. LG Life Sciences Business Overview Table 90. LG Life Sciences Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. LG Life Sciences Injectable Skin Fillers Product Portfolio Table 92. LG Life Sciences Recent Developments Table 93. HUGEL Company Information Table 94. HUGEL Business Overview Table 95. HUGEL Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. HUGEL Injectable Skin Fillers Product Portfolio Table 97. HUGEL Recent Developments Table 98. Genoss Company Information Table 99. Genoss Business Overview Table 100. Genoss Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Genoss Injectable Skin Fillers Product Portfolio Table 102. Genoss Recent Developments Table 103. Galderma Company Information Table 104. Galderma Business Overview Table 105. Galderma Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Galderma Injectable Skin Fillers Product Portfolio Table 107. Galderma Recent Developments Table 108. Elravie (Humedix) Company Information Table 109. Elravie (Humedix) Business Overview Table 110. Elravie (Humedix) Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Elravie (Humedix) Injectable Skin Fillers Product Portfolio Table 112. Elravie (Humedix) Recent Developments Table 113. Croma-Pharma Company Information Table 114. Croma-Pharma Business Overview Table 115. Croma-Pharma Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Croma-Pharma Injectable Skin Fillers Product Portfolio Table 117. Croma-Pharma Recent Developments Table 118. Cleviel (Pharma Research Products) Company Information Table 119. Cleviel (Pharma Research Products) Business Overview Table 120. Cleviel (Pharma Research Products) Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Cleviel (Pharma Research Products) Injectable Skin Fillers Product Portfolio Table 122. Cleviel (Pharma Research Products) Recent Developments Table 123. CG Bio Company Information Table 124. CG Bio Business Overview Table 125. CG Bio Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. CG Bio Injectable Skin Fillers Product Portfolio Table 127. CG Bio Recent Developments Table 128. Caregen Company Information Table 129. Caregen Business Overview Table 130. Caregen Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Caregen Injectable Skin Fillers Product Portfolio Table 132. Caregen Recent Developments Table 133. Bohus BioTech Company Information Table 134. Bohus BioTech Business Overview Table 135. Bohus BioTech Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Bohus BioTech Injectable Skin Fillers Product Portfolio Table 137. Bohus BioTech Recent Developments Table 138. Global Injectable Skin Fillers Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 139. Global Injectable Skin Fillers Sales by Region (2021-2026) & (K Units) Table 140. Global Injectable Skin Fillers Sales Market Share by Region (2021-2026) Table 141. Global Injectable Skin Fillers Sales by Region (2027-2032) & (K Units) Table 142. Global Injectable Skin Fillers Sales Market Share by Region (2027-2032) Table 143. Global Injectable Skin Fillers Revenue by Region (2021-2026) & (US$ Million) Table 144. Global Injectable Skin Fillers Revenue Market Share by Region (2021-2026) Table 145. Global Injectable Skin Fillers Revenue by Region (2027-2032) & (US$ Million) Table 146. Global Injectable Skin Fillers Revenue Market Share by Region (2027-2032) Table 147. North America Injectable Skin Fillers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. North America Injectable Skin Fillers Sales by Country (2021-2026) & (K Units) Table 149. North America Injectable Skin Fillers Sales by Country (2027-2032) & (K Units) Table 150. North America Injectable Skin Fillers Revenue by Country (2021-2026) & (US$ Million) Table 151. North America Injectable Skin Fillers Revenue by Country (2027-2032) & (US$ Million) Table 152. Europe Injectable Skin Fillers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Europe Injectable Skin Fillers Sales by Country (2021-2026) & (K Units) Table 154. Europe Injectable Skin Fillers Sales by Country (2027-2032) & (K Units) Table 155. Europe Injectable Skin Fillers Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Injectable Skin Fillers Revenue by Country (2027-2032) & (US$ Million) Table 157. Asia Pacific Injectable Skin Fillers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Asia Pacific Injectable Skin Fillers Sales by Country (2021-2026) & (K Units) Table 159. Asia Pacific Injectable Skin Fillers Sales by Country (2027-2032) & (K Units) Table 160. Asia Pacific Injectable Skin Fillers Revenue by Country (2021-2026) & (US$ Million) Table 161. Asia Pacific Injectable Skin Fillers Revenue by Country (2027-2032) & (US$ Million) Table 162. South America Injectable Skin Fillers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. South America Injectable Skin Fillers Sales by Country (2021-2026) & (K Units) Table 164. South America Injectable Skin Fillers Sales by Country (2027-2032) & (K Units) Table 165. South America Injectable Skin Fillers Revenue by Country (2021-2026) & (US$ Million) Table 166. South America Injectable Skin Fillers Revenue by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Injectable Skin Fillers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Middle East and Africa Injectable Skin Fillers Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Injectable Skin Fillers Sales by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Injectable Skin Fillers Revenue by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Injectable Skin Fillers Revenue by Country (2027-2032) & (US$ Million) Table 172. Global Injectable Skin Fillers Sales by Type (2021-2026) & (K Units) Table 173. Global Injectable Skin Fillers Sales by Type (2027-2032) & (K Units) Table 174. Global Injectable Skin Fillers Sales Market Share by Type (2021-2026) Table 175. Global Injectable Skin Fillers Sales Market Share by Type (2027-2032) Table 176. Global Injectable Skin Fillers Revenue by Type (2021-2026) & (US$ Million) Table 177. Global Injectable Skin Fillers Revenue by Type (2027-2032) & (US$ Million) Table 178. Global Injectable Skin Fillers Revenue Market Share by Type (2021-2026) Table 179. Global Injectable Skin Fillers Revenue Market Share by Type (2027-2032) Table 180. Global Injectable Skin Fillers Price by Type (2021-2026) & (US$/Unit) Table 181. Global Injectable Skin Fillers Price by Type (2027-2032) & (US$/Unit) Table 182. Global Injectable Skin Fillers Sales by Application (2021-2026) & (K Units) Table 183. Global Injectable Skin Fillers Sales by Application (2027-2032) & (K Units) Table 184. Global Injectable Skin Fillers Sales Market Share by Application (2021-2026) Table 185. Global Injectable Skin Fillers Sales Market Share by Application (2027-2032) Table 186. Global Injectable Skin Fillers Revenue by Application (2021-2026) & (US$ Million) Table 187. Global Injectable Skin Fillers Revenue by Application (2027-2032) & (US$ Million) Table 188. Global Injectable Skin Fillers Revenue Market Share by Application (2021-2026) Table 189. Global Injectable Skin Fillers Revenue Market Share by Application (2027-2032) Table 190. Global Injectable Skin Fillers Price by Application (2021-2026) & (US$/Unit) Table 191. Global Injectable Skin Fillers Price by Application (2027-2032) & (US$/Unit) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Injectable Skin Fillers Distributors List Table 195. Injectable Skin Fillers Customers List Table 196. Injectable Skin Fillers Industry Trends Table 197. Injectable Skin Fillers Industry Drivers Table 198. Injectable Skin Fillers Industry Restraints Table 199. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Injectable Skin Fillers Product Image Figure 5. Global Injectable Skin Fillers Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Injectable Skin Fillers Market Size (2021-2032) & (US$ Million) Figure 7. Global Injectable Skin Fillers Sales (2021-2032) & (K Units) Figure 8. Global Injectable Skin Fillers Average Price (US$/Unit) & (2021-2032) Figure 9. Collagen Product Image Figure 10. CaHA Product Image Figure 11. Hyaluronic Acid Product Image Figure 12. Others Product Image Figure 13. Specialist and Dermatology Clinic Product Image Figure 14. Hospitals and Clinics Product Image Figure 15. Others Product Image Figure 16. Global Injectable Skin Fillers Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Injectable Skin Fillers, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Injectable Skin Fillers Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Injectable Skin Fillers Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Injectable Skin Fillers Sales by Region in 2025 Figure 22. Global Injectable Skin Fillers Revenue by Region in 2025 Figure 23. North America Injectable Skin Fillers Market Size by Country in 2025 Figure 24. North America Injectable Skin Fillers Sales Market Share by Country (2021-2032) Figure 25. North America Injectable Skin Fillers Revenue Market Share by Country (2021-2032) Figure 26. United States Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Injectable Skin Fillers Market Size by Country in 2025 Figure 29. Europe Injectable Skin Fillers Sales Market Share by Country (2021-2032) Figure 30. Europe Injectable Skin Fillers Revenue Market Share by Country (2021-2032) Figure 31. Germany Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Nordic Countries Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific Injectable Skin Fillers Market Size by Country in 2025 Figure 38. Asia Pacific Injectable Skin Fillers Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific Injectable Skin Fillers Revenue Market Share by Country (2021-2032) Figure 40. China Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America Injectable Skin Fillers Market Size by Country in 2025 Figure 49. South America Injectable Skin Fillers Sales Market Share by Country (2021-2032) Figure 50. South America Injectable Skin Fillers Revenue Market Share by Country (2021-2032) Figure 51. Mexico Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Colombia Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Middle East and Africa Injectable Skin Fillers Market Size by Country in 2025 Figure 56. Middle East and Africa Injectable Skin Fillers Sales Market Share by Country (2021-2032) Figure 57. Middle East and Africa Injectable Skin Fillers Revenue Market Share by Country (2021-2032) Figure 58. Turkey Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. UAE Injectable Skin Fillers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Global Injectable Skin Fillers Sales Market Share by Type (2021-2032) Figure 62. Global Injectable Skin Fillers Revenue Market Share by Type (2021-2032) Figure 63. Global Injectable Skin Fillers Price (US$/Unit) by Type (2021-2032) Figure 64. Global Injectable Skin Fillers Sales Market Share by Application (2021-2032) Figure 65. Global Injectable Skin Fillers Revenue Market Share by Application (2021-2032) Figure 66. Global Injectable Skin Fillers Price (US$/Unit) by Application (2021-2032) Figure 67. Injectable Skin Fillers Value Chain Figure 68. Injectable Skin Fillers Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Injectable Skin Fillers Industry Opportunities and Challenges

Scope & coverage.

Types
  • Collagen
  • CaHA
  • Hyaluronic Acid
  • Others
Applications
  • Specialist and Dermatology Clinic
  • Hospitals and Clinics
  • Others
Companies covered
  • Jingjia Medical
  • Bloomage Bio
  • Haohai Biological
  • Beijing IMEIK
  • AbbVie
  • Teoxane
  • Suneva Medical
  • Sinclair
  • SciVision Biotech
  • Q.O.Fill (JW Pharmaceutical)
  • Prollenium
  • Merz
  • Medytox
  • Matex-Lab
  • LG Life Sciences
  • HUGEL
  • Genoss
  • Galderma
  • Elravie (Humedix)
  • Croma-Pharma
  • Cleviel (Pharma Research Products)
  • CG Bio
  • Caregen
  • Bohus BioTech

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Injectable Skin Fillers Market Size (2021-2032)
  4. 2.2.2 Global Injectable Skin Fillers Sales (2021-2032)
  5. 2.2.3 Global Injectable Skin Fillers Market Average Price (2021-2032)
  6. 2.3 Injectable Skin Fillers by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Collagen
  9. 2.3.3 CaHA
  10. 2.3.4 Hyaluronic Acid
  11. 2.3.5 Others
  12. 2.4 Injectable Skin Fillers by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Specialist and Dermatology Clinic
  15. 2.4.3 Hospitals and Clinics
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Injectable Skin Fillers Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Injectable Skin Fillers Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Injectable Skin Fillers Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Injectable Skin Fillers Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Injectable Skin Fillers Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Injectable Skin Fillers, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Injectable Skin Fillers, Product Type & Application
  8. 3.8 Global Manufacturers of Injectable Skin Fillers, Established Date
  9. 3.9 Global Injectable Skin Fillers Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Jingjia Medical
  2. 4.1.1 Jingjia Medical Company Information
  3. 4.1.2 Jingjia Medical Business Overview
  4. 4.1.3 Jingjia Medical Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Jingjia Medical Injectable Skin Fillers Product Portfolio
  6. 4.1.5 Jingjia Medical Recent Developments
  7. 4.2 Bloomage Bio
  8. 4.2.1 Bloomage Bio Company Information
  9. 4.2.2 Bloomage Bio Business Overview
  10. 4.2.3 Bloomage Bio Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Bloomage Bio Injectable Skin Fillers Product Portfolio
  12. 4.2.5 Bloomage Bio Recent Developments
  13. 4.3 Haohai Biological
  14. 4.3.1 Haohai Biological Company Information
  15. 4.3.2 Haohai Biological Business Overview
  16. 4.3.3 Haohai Biological Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Haohai Biological Injectable Skin Fillers Product Portfolio
  18. 4.3.5 Haohai Biological Recent Developments
  19. 4.4 Beijing IMEIK
  20. 4.4.1 Beijing IMEIK Company Information
  21. 4.4.2 Beijing IMEIK Business Overview
  22. 4.4.3 Beijing IMEIK Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Beijing IMEIK Injectable Skin Fillers Product Portfolio
  24. 4.4.5 Beijing IMEIK Recent Developments
  25. 4.5 AbbVie
  26. 4.5.1 AbbVie Company Information
  27. 4.5.2 AbbVie Business Overview
  28. 4.5.3 AbbVie Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 AbbVie Injectable Skin Fillers Product Portfolio
  30. 4.5.5 AbbVie Recent Developments
  31. 4.6 Teoxane
  32. 4.6.1 Teoxane Company Information
  33. 4.6.2 Teoxane Business Overview
  34. 4.6.3 Teoxane Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Teoxane Injectable Skin Fillers Product Portfolio
  36. 4.6.5 Teoxane Recent Developments
  37. 4.7 Suneva Medical
  38. 4.7.1 Suneva Medical Company Information
  39. 4.7.2 Suneva Medical Business Overview
  40. 4.7.3 Suneva Medical Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Suneva Medical Injectable Skin Fillers Product Portfolio
  42. 4.7.5 Suneva Medical Recent Developments
  43. 4.8 Sinclair
  44. 4.8.1 Sinclair Company Information
  45. 4.8.2 Sinclair Business Overview
  46. 4.8.3 Sinclair Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sinclair Injectable Skin Fillers Product Portfolio
  48. 4.8.5 Sinclair Recent Developments
  49. 4.9 SciVision Biotech
  50. 4.9.1 SciVision Biotech Company Information
  51. 4.9.2 SciVision Biotech Business Overview
  52. 4.9.3 SciVision Biotech Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 SciVision Biotech Injectable Skin Fillers Product Portfolio
  54. 4.9.5 SciVision Biotech Recent Developments
  55. 4.10 Q.O.Fill (JW Pharmaceutical)
  56. 4.10.1 Q.O.Fill (JW Pharmaceutical) Company Information
  57. 4.10.2 Q.O.Fill (JW Pharmaceutical) Business Overview
  58. 4.10.3 Q.O.Fill (JW Pharmaceutical) Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Q.O.Fill (JW Pharmaceutical) Injectable Skin Fillers Product Portfolio
  60. 4.10.5 Q.O.Fill (JW Pharmaceutical) Recent Developments
  61. 4.11 Prollenium
  62. 4.11.1 Prollenium Company Information
  63. 4.11.2 Prollenium Business Overview
  64. 4.11.3 Prollenium Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Prollenium Injectable Skin Fillers Product Portfolio
  66. 4.11.5 Prollenium Recent Developments
  67. 4.12 Merz
  68. 4.12.1 Merz Company Information
  69. 4.12.2 Merz Business Overview
  70. 4.12.3 Merz Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Merz Injectable Skin Fillers Product Portfolio
  72. 4.12.5 Merz Recent Developments
  73. 4.13 Medytox
  74. 4.13.1 Medytox Company Information
  75. 4.13.2 Medytox Business Overview
  76. 4.13.3 Medytox Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Medytox Injectable Skin Fillers Product Portfolio
  78. 4.13.5 Medytox Recent Developments
  79. 4.14 Matex-Lab
  80. 4.14.1 Matex-Lab Company Information
  81. 4.14.2 Matex-Lab Business Overview
  82. 4.14.3 Matex-Lab Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Matex-Lab Injectable Skin Fillers Product Portfolio
  84. 4.14.5 Matex-Lab Recent Developments
  85. 4.15 LG Life Sciences
  86. 4.15.1 LG Life Sciences Company Information
  87. 4.15.2 LG Life Sciences Business Overview
  88. 4.15.3 LG Life Sciences Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 LG Life Sciences Injectable Skin Fillers Product Portfolio
  90. 4.15.5 LG Life Sciences Recent Developments
  91. 4.16 HUGEL
  92. 4.16.1 HUGEL Company Information
  93. 4.16.2 HUGEL Business Overview
  94. 4.16.3 HUGEL Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 HUGEL Injectable Skin Fillers Product Portfolio
  96. 4.16.5 HUGEL Recent Developments
  97. 4.17 Genoss
  98. 4.17.1 Genoss Company Information
  99. 4.17.2 Genoss Business Overview
  100. 4.17.3 Genoss Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Genoss Injectable Skin Fillers Product Portfolio
  102. 4.17.5 Genoss Recent Developments
  103. 4.18 Galderma
  104. 4.18.1 Galderma Company Information
  105. 4.18.2 Galderma Business Overview
  106. 4.18.3 Galderma Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Galderma Injectable Skin Fillers Product Portfolio
  108. 4.18.5 Galderma Recent Developments
  109. 4.19 Elravie (Humedix)
  110. 4.19.1 Elravie (Humedix) Company Information
  111. 4.19.2 Elravie (Humedix) Business Overview
  112. 4.19.3 Elravie (Humedix) Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Elravie (Humedix) Injectable Skin Fillers Product Portfolio
  114. 4.19.5 Elravie (Humedix) Recent Developments
  115. 4.20 Croma-Pharma
  116. 4.20.1 Croma-Pharma Company Information
  117. 4.20.2 Croma-Pharma Business Overview
  118. 4.20.3 Croma-Pharma Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Croma-Pharma Injectable Skin Fillers Product Portfolio
  120. 4.20.5 Croma-Pharma Recent Developments
  121. 4.21 Cleviel (Pharma Research Products)
  122. 4.21.1 Cleviel (Pharma Research Products) Company Information
  123. 4.21.2 Cleviel (Pharma Research Products) Business Overview
  124. 4.21.3 Cleviel (Pharma Research Products) Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Cleviel (Pharma Research Products) Injectable Skin Fillers Product Portfolio
  126. 4.21.5 Cleviel (Pharma Research Products) Recent Developments
  127. 4.22 CG Bio
  128. 4.22.1 CG Bio Company Information
  129. 4.22.2 CG Bio Business Overview
  130. 4.22.3 CG Bio Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 CG Bio Injectable Skin Fillers Product Portfolio
  132. 4.22.5 CG Bio Recent Developments
  133. 4.23 Caregen
  134. 4.23.1 Caregen Company Information
  135. 4.23.2 Caregen Business Overview
  136. 4.23.3 Caregen Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Caregen Injectable Skin Fillers Product Portfolio
  138. 4.23.5 Caregen Recent Developments
  139. 4.24 Bohus BioTech
  140. 4.24.1 Bohus BioTech Company Information
  141. 4.24.2 Bohus BioTech Business Overview
  142. 4.24.3 Bohus BioTech Injectable Skin Fillers Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Bohus BioTech Injectable Skin Fillers Product Portfolio
  144. 4.24.5 Bohus BioTech Recent Developments
5 Global Injectable Skin Fillers Market Scenario by Region
  1. 5.1 Global Injectable Skin Fillers Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Injectable Skin Fillers Sales by Region: 2021-2032
  3. 5.2.1 Global Injectable Skin Fillers Sales by Region: 2021-2026
  4. 5.2.2 Global Injectable Skin Fillers Sales by Region: 2027-2032
  5. 5.3 Global Injectable Skin Fillers Revenue by Region: 2021-2032
  6. 5.3.1 Global Injectable Skin Fillers Revenue by Region: 2021-2026
  7. 5.3.2 Global Injectable Skin Fillers Revenue by Region: 2027-2032
  8. 5.4 North America Injectable Skin Fillers Market Facts & Figures by Country
  9. 5.4.1 North America Injectable Skin Fillers Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Injectable Skin Fillers Sales by Country (2021-2032)
  11. 5.4.3 North America Injectable Skin Fillers Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Injectable Skin Fillers Market Facts & Figures by Country
  15. 5.5.1 Europe Injectable Skin Fillers Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Injectable Skin Fillers Sales by Country (2021-2032)
  17. 5.5.3 Europe Injectable Skin Fillers Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Injectable Skin Fillers Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Injectable Skin Fillers Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Injectable Skin Fillers Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Injectable Skin Fillers Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Injectable Skin Fillers Market Facts & Figures by Country
  36. 5.7.1 South America Injectable Skin Fillers Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Injectable Skin Fillers Sales by Country (2021-2032)
  38. 5.7.3 South America Injectable Skin Fillers Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.7.7 Colombia
  43. 5.8 Middle East and Africa Injectable Skin Fillers Market Facts & Figures by Country
  44. 5.8.1 Middle East and Africa Injectable Skin Fillers Market Size by Country: 2021 VS 2025 VS 2032
  45. 5.8.2 Middle East and Africa Injectable Skin Fillers Sales by Country (2021-2032)
  46. 5.8.3 Middle East and Africa Injectable Skin Fillers Revenue by Country (2021-2032)
  47. 5.8.4 Turkey
  48. 5.8.5 Saudi Arabia
  49. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Injectable Skin Fillers Sales by Type (2021-2032)
  2. 6.1.1 Global Injectable Skin Fillers Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Injectable Skin Fillers Sales Market Share by Type (2021-2032)
  4. 6.2 Global Injectable Skin Fillers Revenue by Type (2021-2032)
  5. 6.2.1 Global Injectable Skin Fillers Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Injectable Skin Fillers Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Injectable Skin Fillers Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Injectable Skin Fillers Sales by Application (2021-2032)
  2. 7.1.1 Global Injectable Skin Fillers Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Injectable Skin Fillers Sales Market Share by Application (2021-2032)
  4. 7.2 Global Injectable Skin Fillers Revenue by Application (2021-2032)
  5. 7.2.1 Global Injectable Skin Fillers Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Injectable Skin Fillers Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Injectable Skin Fillers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Injectable Skin Fillers Value Chain Analysis
  2. 8.1.1 Injectable Skin Fillers Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Injectable Skin Fillers Production Mode & Process
  5. 8.2 Injectable Skin Fillers Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Injectable Skin Fillers Distributors
  8. 8.2.3 Injectable Skin Fillers Customers
9 Global Injectable Skin Fillers Analyzing Market Dynamics
  1. 9.1 Injectable Skin Fillers Industry Trends
  2. 9.2 Injectable Skin Fillers Industry Drivers
  3. 9.3 Injectable Skin Fillers Industry Opportunities and Challenges
  4. 9.4 Injectable Skin Fillers Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.